Lifespanning Rx launched the Peptide Explorer online educational tool designed to help users organize health goals and explore up to three therapy candidates before clinical evaluation.
Public source
Publisher name
Public post
LifespanningRx Launches Peptide Explorer to Support Informed, Clinician-Guided Therapy Discussions. MIAMI, FL, UNITED STATES, August 31, 2026 /EINPresswire.com/ -- New e…
Company
Lifespanning
Where Longevity Science Becomes Lifespanning. #safepeptides
- Industry
- Health and Human Services
- Location
- Miami, US
- Company size
- 2–10 employees
About Lifespanning
Lifespanning is a global longevity ecosystem uniting science, education, media, curated wellness solutions, and physician-guided precision medicine to help people live longer and live better. Through Lifespanning Magazine, formerly Biohackers Magazine—the world’s first publication dedicated to biohacking, longevity, and human performance—we connect a community of more than 5 million enthusiasts with cutting-edge research, expert perspectives, exclusive interviews, and breakthrough strategies for optimizing health and extending healthspan. Through the Lifespanning Marketplace, we provide access to a carefully curated selection of longevity, wellness, recovery, and human-performance products from forward-thinking brands—helping consumers navigate an increasingly complex industry with greater confidence. Through LifespanningRx, our nationwide telehealth platform, we provide personalized peptide and longevity programs supported by licensed medical evaluations, optional laboratory testing, and access to U.S. compounding pharmacies. Our programs are designed to support biological aging, metabolic health, cognitive performance, recovery, and vitality—without mandatory subscriptions. With more than 100 expert contributors and a growing network of medical providers, scientists, pharmacies, innovators, and industry pioneers, Lifespanning bridges the gap between longevity science and real-world application.
See moreLatest activity
Latest activity from Lifespanning
4 signals
Presence & Recognition
Lifespanning published an article in the CB Herald today.
Legal & Regulatory
Lifespanning notes that Mississippi and South Carolina have issued clear warnings against using research-grade peptides in patient care, including that healthcare providers cannot recommend, supply, prescribe, or administer these products.
Products & Services
Lifespanning launched the LifespanningRx Peptide Explorer to support informed, clinician-guided therapy discussions.
Discover more
Similar signals
Similar public activity from other companies.
Products & Services
NEXT|HEALTH
NEXT|HEALTH introduced the Next Health Peptide Pen, a provider-supervised delivery system that replaces syringes and complex instructions with precision-dosed, regulated protocols.
Products & Services
Longevity.Technology
Longevity.Technology is launching Longevity Bites to tackle big questions in the field with clearer, more accessible explanations of the science behind longevity.
Products & Services
Musely
Musely launched The Peptide Serum, the first prescription longevity treatment combining high-strength 3% GHK-Cu copper peptide with metformin.
Products & Services
ISSCA International Society for Stem Cell Application
ISSCA International Society for Stem Cell Application launched the Advanced Peptide Certification 2.0 program, which includes two complimentary peptide medicine books, a bonus module on practical clinical cases, and Spanish content with English subtitles.
Products & Services
Buck Institute for Research on Aging